503 related articles for article (PubMed ID: 26126423)
1. Long-Term Outcome After Resection of Huge Hepatocellular Carcinoma ≥ 10 cm: Single-Institution Experience with 471 Patients.
Hwang S; Lee YJ; Kim KH; Ahn CS; Moon DB; Ha TY; Song GW; Jung DH; Lee SG
World J Surg; 2015 Oct; 39(10):2519-28. PubMed ID: 26126423
[TBL] [Abstract][Full Text] [Related]
2. Huge hepatocellular carcinoma greater than 10 cm in diameter worsens prognosis by causing distant recurrence after curative resection.
Wakayama K; Kamiyama T; Yokoo H; Orimo T; Shimada S; Einama T; Kamachi H; Taketomi A
J Surg Oncol; 2017 Mar; 115(3):324-329. PubMed ID: 28192617
[TBL] [Abstract][Full Text] [Related]
3. Is hepatectomy for huge hepatocellular carcinoma (≥ 10 cm in diameter) safe and effective? A single-center experience.
Yang J; Li C; Wen TF; Yan LN; Li B; Wang WT; Yang JY; Xu MQ
Asian Pac J Cancer Prev; 2014; 15(17):7069-77. PubMed ID: 25227793
[TBL] [Abstract][Full Text] [Related]
4. Actual 10-Year Survivors After Resection of Hepatocellular Carcinoma.
Zheng J; Kuk D; Gönen M; Balachandran VP; Kingham TP; Allen PJ; D'Angelica MI; Jarnagin WR; DeMatteo RP
Ann Surg Oncol; 2017 May; 24(5):1358-1366. PubMed ID: 27921192
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of prognostic factors on recurrence after curative resections for hepatocellular carcinoma.
Han JH; Kim DG; Na GH; Kim EY; Lee SH; Hong TH; You YK
World J Gastroenterol; 2014 Dec; 20(45):17132-40. PubMed ID: 25493027
[TBL] [Abstract][Full Text] [Related]
6. Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma.
Liu C; Sun L; Xu J; Zhao Y
World J Surg Oncol; 2016 Apr; 14():100. PubMed ID: 27038790
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Patients With Hepatocellular Carcinomas That Do Not Produce α-Fetoprotein.
Agopian VG; Harlander-Locke MP; Markovic D; Zarrinpar A; Kaldas FM; Cheng EY; Yersiz H; Farmer DG; Hiatt JR; Busuttil RW
JAMA Surg; 2017 Jan; 152(1):55-64. PubMed ID: 27706479
[TBL] [Abstract][Full Text] [Related]
8. [A new prognostic score system of hepatocellular carcinoma following hepatectomy].
Wang YK; Bi XY; Li ZY; Zhao H; Zhao JJ; Zhou JG; Huang Z; Zhang YF; Li MX; Chen X; Wu XL; Mao R; Hu XH; Hu HJ; Liu JM; Cai JQ
Zhonghua Zhong Liu Za Zhi; 2017 Dec; 39(12):903-909. PubMed ID: 29262506
[No Abstract] [Full Text] [Related]
9. [Impact of serum α-fetoprotein level on short-term recurrence after R0 resection in primary hepatocellular carcinoma].
Li SP; Wu LQ
Zhonghua Wai Ke Za Zhi; 2013 Jul; 51(7):600-3. PubMed ID: 24256584
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the risk factors of untransplantable recurrence after primary curative resection for patients with hepatocellular carcinoma.
Ho CM; Wu CY; Lee PH; Lai HS; Ho MC; Wu YM; Hu RH
Ann Surg Oncol; 2013 Aug; 20(8):2526-33. PubMed ID: 23504121
[TBL] [Abstract][Full Text] [Related]
11. Outcome of patients with huge hepatocellular carcinoma after primary resection and treatment of recurrent lesions.
Lee SG; Hwang S; Jung JP; Lee YJ; Kim KH; Ahn CS
Br J Surg; 2007 Mar; 94(3):320-6. PubMed ID: 17205495
[TBL] [Abstract][Full Text] [Related]
12. The Impact of Tumor Size on Long-Term Survival Outcomes After Resection of Solitary Hepatocellular Carcinoma: Single-Institution Experience with 2558 Patients.
Hwang S; Lee YJ; Kim KH; Ahn CS; Moon DB; Ha TY; Song GW; Jung DH; Lee SG
J Gastrointest Surg; 2015 Jul; 19(7):1281-90. PubMed ID: 25956724
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Prediction Models for Resection of Large Hepatocellular Carcinoma: A Korean Multicenter Study.
Hwang S; Joh JW; Wang HJ; Kim DG; Kim KS; Suh KS; Kim SH; Yu HC; Cho CK; Lee YJ; Kim KH; Kim JM; Kim BW; Lee SG
World J Surg; 2018 Aug; 42(8):2579-2591. PubMed ID: 29340726
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcomes of repeat hepatic resection in patients with recurrent hepatocellular carcinoma and analysis of recurrent types and their prognosis: a single-center experience in China.
Huang ZY; Liang BY; Xiong M; Zhan DQ; Wei S; Wang GP; Chen YF; Chen XP
Ann Surg Oncol; 2012 Aug; 19(8):2515-25. PubMed ID: 22395985
[TBL] [Abstract][Full Text] [Related]
15. Preoperative serum liver enzyme markers for predicting early recurrence after curative resection of hepatocellular carcinoma.
Wang ZX; Jiang CP; Cao Y; Zhang G; Chen WB; Ding YT
Hepatobiliary Pancreat Dis Int; 2015 Apr; 14(2):178-85. PubMed ID: 25865691
[TBL] [Abstract][Full Text] [Related]
16. The influence of histological differentiation grade on the outcome of liver resection for hepatocellular carcinomas 2 cm or smaller in size.
Sasaki K; Matsuda M; Ohkura Y; Kawamura Y; Inoue M; Hashimoto M; Ikeda K; Kumada H; Watanabe G
World J Surg; 2015 May; 39(5):1134-41. PubMed ID: 25287916
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of microvascular invasion in tumor stage for hepatocellular carcinoma.
Park YK; Song SK; Kim BW; Park SK; Chung CW; Wang HJ
World J Surg Oncol; 2017 Dec; 15(1):225. PubMed ID: 29258507
[TBL] [Abstract][Full Text] [Related]
18. Significance of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and prognostic nutrition index as preoperative predictors of early mortality after liver resection for huge (≥10 cm) hepatocellular carcinoma.
Goh BK; Kam JH; Lee SY; Chan CY; Allen JC; Jeyaraj P; Cheow PC; Chow PK; Ooi LL; Chung AY
J Surg Oncol; 2016 May; 113(6):621-7. PubMed ID: 26861568
[TBL] [Abstract][Full Text] [Related]
19. Microvascular invasion patterns affect survival in hepatocellular carcinoma patients after second hepatectomy.
Hou YF; Wei YG; Yang JY; Wen TF; Xu MQ; Yan LN; Li B; Chen KF
J Surg Res; 2016 Jan; 200(1):82-90. PubMed ID: 26259778
[TBL] [Abstract][Full Text] [Related]
20. Serum Insulin-Like Growth Factor-1 (IGF-1): a Novel Prognostic Factor for Early Recurrence of Hepatocellular Carcinoma (HCC).
Yao Y; Mao W; Dong M; Yang D; Li W; Chen Y
Clin Lab; 2017 Feb; 63(2):261-270. PubMed ID: 28182337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]